Glatiramer and suspected multiple sclerosis. No proven advantage.
出版信息
Prescrire Int. 2010 Aug;19(108):160.
PMID:20941852
Abstract
摘要
相似文献
1
Glatiramer and suspected multiple sclerosis. No proven advantage.
Prescrire Int. 2010 Aug;19(108):160.
2
The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Semin Neurol. 2013 Feb;33(1):13-25. doi: 10.1055/s-0033-1343792. Epub 2013 May 25.
3
[Diagnostics and drug therapy of multiple sclerosis].
Duodecim. 2002;118(13):1411-23.
4
Patient and family fact sheet. Current treatments for multiple sclerosis.
Neurologist. 2005 Mar;11(2):137-8. doi: 10.1097/01.nrl.0000155637.49543.27.
5
Approaches to neuroprotective strategies in multiple sclerosis.
Expert Opin Pharmacother. 2010 Dec;11(17):2869-78. doi: 10.1517/14656566.2010.508070. Epub 2010 Aug 5.
6
[Drug therapy of multiple sclerosis].
Duodecim. 1999;115(4):403-7.
7
[Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis].
Medicina (B Aires). 2001;61(4):470-80.
8
[New therapeutic methods in the treatment of multiple sclerosis].
Nervenarzt. 1996 Nov;67(11 Suppl Neue Ther):1-12.
9
Diagnosis and disease modifying treatments in multiple sclerosis.
Postgrad Med J. 2005 Sep;81(959):556-61. doi: 10.1136/pgmj.2004.031294.
10
Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
J Neurol Sci. 2005 Jun 15;233(1-2):173-7. doi: 10.1016/j.jns.2005.03.030. Epub 2005 Apr 20.
Zotero 插件